Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group
Journal of Pediatric Gastroenterology and Nutrition · 2025-02 · 80 (2) · 374-393
DOI: 10.1002/jpn3.12378 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 31.12.2024. Verfasst von Patrick F van Rheenen und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology, Hepatology, and Nutrition, University Medical Center Groningen, University of Groningen, Groningen, The Ne…. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Society for Paediatric Gastroenterology Hepatology and Nutrition.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
We aimed to provide an evidence‐supported approach to diagnose, monitor, and treat children with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC).
Methods
The core group formulated seven PICO‐structured clinical questions. A systematic literature search from inception to December 2022 was conducted by a medical librarian using MEDLINE and EMBASE. Core messages from the literature were phrased as position statements and then circulated to a sounding board composed of international experts in pediatric gastroenterology and hepatology, histopathology, adult gastroenterology and hepatology, radiology, and surgery. Statements reaching at least 80% agreement were considered as final. The other statements were refined and then subjected to a second online vote or rejection.
Results
Regular screening for gamma‐glutamyltransferase (GGT) is essential for detecting possible biliary disease in children with IBD. MR cholangiopancreatography is the radiological modality of choice for establishing the diagnosis of PSC. Liver biopsy is relevant in the evaluation of small duct PSC or autoimmune hepatitis. Children who do not have known IBD at the time of PSC diagnosis should undergo initial screening with fecal calprotectin for asymptomatic colitis, and then at least once yearly thereafter. Children with a cholestatic liver enzyme profile can be considered for treatment with ursodeoxycholic acid and can continue if there is a meaningful reduction or normalization in GGT. Oral vancomycin may have a beneficial effect on GGT and intestinal inflammation, but judicious use is recommended due to the lack of long‐term studies. Children with PSC–IBD combined with convincing features of autoimmune hepatitis may benefit from corticosteroids and antimetabolites.
Conclusions
We present state‐of‐the‐art guidance on the diagnostic criteria, follow‐up strategies, and therapeutic strategies and point out research gaps in children and adolescents with PSC–IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatric Gastroenterology, Hepatology, and Nutrition, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Children's Hospital, University of Helsinki and HUS, Helsinki, Finland.
- Department of Paediatric Gastroenterology, and Nutrition, Royal Hospital for Children and Young People, Edinburgh, UK.
- Sapienza University of Rome - Umberto I Hospital, Rome, Italy.
- Department of Radiology, King's College Hospital, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
- Children's Health Ireland and University College Dublin, Dublin, Ireland.
ORCID-Profile: Patrick F van Rheenen
Förderung
- European Society for Paediatric Gastroenterology Hepatology and Nutrition
Zitieren
APA
van Rheenen, P. F., Kolho, K. L., Russell, R. K., Aloi, M., Deganello, A., Hussey, S., Junge, N., De Laffolie, J., Deneau, M. R., Fitzpatrick, E., Griffiths, A. M., Hojsak, I., Nicastro, E., Nita, A., Pakarinen, M., Ricciuto, A., de Ridder, L., Sonzogni, A., Tenca, A., …, & Indolfi, G. (2025). Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group. Journal of Pediatric Gastroenterology and Nutrition, 80(2), 374-393. https://doi.org/10.1002/jpn3.12378
Vancouver
van Rheenen PF, Kolho KL, Russell RK, Aloi M, Deganello A, Hussey S, et al. Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group. Journal of Pediatric Gastroenterology and Nutrition. 2025;80(2):374-393. doi:10.1002/jpn3.12378
BibTeX
@article{vanRheenen2025,
author = {van Rheenen, Patrick F and Kolho, Kaija-Leena and Russell, Richard K and Aloi, Marina and Deganello, Annamaria and Hussey, Séamus and Junge, Norman and De Laffolie, Jan and Deneau, Mark R and Fitzpatrick, Emer and Griffiths, Anne M and Hojsak, Iva and Nicastro, Emanuele and Nita, Andreia and Pakarinen, Mikko and Ricciuto, Amanda and de Ridder, Lissy and Sonzogni, Aurelio and Tenca, Andrea and Samyn, Marianne and Indolfi, Giuseppe},
title = {Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2025},
volume = {80},
number = {2},
pages = {374--393},
doi = {10.1002/jpn3.12378}
}
EUVIMED